Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA No Longer Publishing Quarterly PMA And HDE Decisions

Executive Summary

The US FDA has stopped publishing its list of approvals and denials of premarket approval applications (PMAs) and humanitarian device exemptions (HDEs) in the Federal Register on a quarterly basis. The agency says the change will save money and resources.

You may also be interested in...

FDA Proposes End To Quarterly Reporting On HDE, PMA Decisions

A proposal from the US FDA would end quarterly publication of PMA and Humanitarian Device Exemption verdicts in the Federal Register. The agency says the practice is inefficient and duplicates online publication.

From The Farm To The OR: Pigs Show More Promise As Organ Donors

Surgeons in Alabama have taken a giant leap forward to making pig kidneys a viable option for humans with end-stage renal disease.

Senators Ask FTC To Investigate COVID-19 Test Price-Gouging

Democrats Markey and Blumenthal say pandemic not only has led to supply shortages but to “predatory and profiteering behavior,” including sales of fraudulent kits or exorbitant prices for approved devices.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts